Skip to main content
. 2020 May 12;21:174. doi: 10.1186/s12882-020-01833-6

Table 2.

Effect of baicalin-lysozyme on metabolic disorder (triglyceride, cholesterol, and malondialdehyde) in rats with diabetic nephropathy

Group N TG(umol/g of protein) TC(umol/g of protein) MDA(nmol/mg of protein)
Control 10 114.13±36.17 85.1±25.57 2.75±0.67
DN 15 1125.6±154.47*** 1544.25±540.13*** 12.11±2.42***
DN/B 10 353.42±81.87**### 391.24±48.03### 5.78±0.74**###
DN/B+L 10 203.68±62.34### 308.4±61.69### 3.46±0.49###$

Data are presented as the mean ± standard deviation **P < 0.01 vs. the control group. #P < 0.05, ##P < 0.01 vs. the DN group. $$P < 0.01 vs. the control group